Sabby Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,594
Closed -$1.77M 208
2021
Q2
$1.77M Sell
5,594
-1,365
-20% -$3.41K 0.25% 62
2021
Q1
$2.26M Buy
6,959
+6,104
+714% +$22.1K 0.44% 45
2020
Q4
$53K Buy
855
+61
+8% +$28 0.01% 100
2020
Q3
$28K Hold
794
﹤0.01% 128
2020
Q2
$43K Buy
+794
New +$383 0.01% 92
2018
Q2
Sell
-56
Closed -$124K 190
2018
Q1
$124K Sell
56
-179
-76% -$4.1K 0.01% 133
2017
Q4
$589K Sell
235
-29
-11% -$892 0.05% 99
2017
Q3
$490K Buy
+264
New +$3.07K 0.03% 101
2016
Q2
Sell
-37
Closed -$205K 339
2016
Q1
$205K Buy
+37
New +$1.58K 0.01% 258

Other funds holding ASXC

Sabby Management's ASXC Position: Q3 2021 in Review

Sabby Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2021, closing a stake of 931,414 shares — an estimated $2.95M sold.

Sabby Management first reported a position in ASXC in Q2 2015 and held it in 9 quarters. The position peaked at $7.48M in Q1 2021. 111 funds tracked by Wall St. Rank hold ASXC as of Q3 2021.

  • Sabby Management reported no remaining Asensus Surgical, Inc. position as of Q3 2021 after selling out during the quarter.
  • Sabby Management sold 931,414 Asensus Surgical, Inc. shares in Q3 2021, an estimated $2.95M.
  • Sabby Management first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 9 quarters.
  • Sabby Management's Asensus Surgical, Inc. position peaked at $7.48M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2021.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.